R3 Bio

R3 Bio is a regenerative medicine company engineering biological systems for therapeutic applications. It develops genetically engineered whole organ systems, including non-sentient monkey models for medical testing and toxicology. A key, experimental focus involves creating human biological duplicates, envisioned for organ harvesting and eventual full body replacement.

Co-founded by John Schloendorn and Alice Gilman, R3 Bio operated privately for years. Schloendorn, a biotech outsider, was driven by a radical vision for extended human lifespans, inspired by the biological possibility of bodies functioning with minimal brain activity. This unconventional insight underpins the company's unique approach to regenerative science.

R3 Bio currently serves research institutions requiring advanced testing models. Its long-term vision addresses human aging through the provision of new bodies and replacement organs. The company aims to offer groundbreaking solutions for life extension, navigating the profound ethical implications inherent in its pioneering biomedical endeavors.